Finished
Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer
NCT04324567 · Oslo University Hospital · Updated 3 April 2023
- What is being tested
- Not stated
- For
- Locally Advanced Rectal Cancer; Abdominoperineal Resection
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 100 years. About 55 people. The full rules are on the registry page.
- Where
- Norway
- When
- Starts or started 9 Oct 2019, ends 5 March 2022. Registered 27 March 2020.
- Results
- None posted yet.
In the researchers' words
The intention of the study is to explore metabolic and inflammatory parameters in the pelvis and systemically after abdominoperineal resection (APR) for locally advanced rectal cancer (LARC) in patients that have received radiation therapy before surgery. In this study the inflammatory response after laparoscopic robot-assisted APR for LARC will be compared to results obtained in a recent cohort of patients operated with open APR for LARC, which will serve as the control population.
Sites
- The Norwegian Radium Hospital Oslo University HospitalOslo, Norway